Dokter R. CLAEYS, klinische biologie
0882.782.944 · rovalta.com · 28/09/2026
Dokter R. CLAEYS, klinische biologie
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBODokter R. CLAEYS, klinische biologie is a Private limited company incorporated in 2006. Its main activity is: Specialist medical practice activities. Its registered office is in Scherpenheuvel-Zichem.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0882.782.944
- Incorporation
- 14/07/2006
- Legal form
- Private limited company
- Registered office
- Prinsenbosstraat(KAG) 103
3270 Scherpenheuvel-Zichem · FlandreSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 20 filingsTrend over 18 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 51,6 k € | +44.3% | 35,8 k € | -8.8% | 39,2 k € | -55.5% | 88,1 k € | +53.8% | 57,3 k € |
| EBITDA | 50,5 k € | +72.2% | 29,3 k € | -24.2% | 38,7 k € | -56.0% | 87,9 k € | +54.5% | 56,9 k € |
| Operating result | 49,4 k € | +75.0% | 28,2 k € | -10.7% | 31,6 k € | -61.0% | 81,2 k € | +61.7% | 50,2 k € |
| Net result | 38,9 k € | +97.4% | 19,7 k € | -8.0% | 21,4 k € | -62.8% | 57,6 k € | +67.4% | 34,4 k € |
| Balance sheet | |||||||||
| Equity | 209,8 k € | +14.1% | 183,8 k € | -3.6% | 190,7 k € | +12.6% | 169,3 k € | +51.6% | 111,7 k € |
| Total assets | 236,9 k € | +21.3% | 195,3 k € | -8.6% | 213,7 k € | -1.2% | 216,2 k € | +41.6% | 152,7 k € |
| Cash | 110,8 k € | +35.4% | 81,8 k € | -7.4% | 88,3 k € | -30.1% | 126,4 k € | +78.3% | 70,9 k € |
| Debts | 27,2 k € | +136% | 11,5 k € | -49.9% | 23 k € | -51.0% | 46,9 k € | +14.4% | 41 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
ROWAN CLAEYS | Directorsince 31/07/2006Managersince 31/07/2006ended |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
Rowan Gaston Pierre Claeys | Manager |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/06/2026 | 20/06/2025 | 28/06/2024 | 29/06/2023 | 29/06/2022 | 25/06/2021 |
| General meeting | 24/06/2026 | 16/06/2025 | 16/06/2024 | 28/06/2023 | 10/06/2022 | 10/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 24/06/2026 | 30/06/2026 | Dutch | |
| Abridged model | 31/12/2024 | 16/06/2025 | 20/06/2025 | Dutch | |
| Abridged model | 31/12/2023 | 16/06/2024 | 28/06/2024 | Dutch | |
| Abridged model | 31/12/2022 | 28/06/2023 | 29/06/2023 | Dutch | |
| Abridged model | 31/12/2021 | 10/06/2022 | 29/06/2022 | Dutch | |
| Abridged model | 31/12/2020 | 10/06/2021 | 25/06/2021 | Dutch | |
| Abridged model | 31/12/2019 | 31/07/2020 | 26/08/2020 | Dutch | |
| Abridged model | 31/12/2018 | 11/06/2019 | 30/07/2019 | Dutch | |
| Abridged model | 31/12/2017 | 11/06/2018 | 31/08/2018 | Dutch | |
| Abridged model | 31/12/2016 | 10/06/2017 | 31/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 10/06/2016 | 31/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 10/06/2015 | 30/09/2015 | Dutch | |
| Abridged model | 31/12/2013 | 10/06/2014 | 29/09/2014 | Dutch | |
| Abridged model | 31/12/2012 | 10/06/2013 | 30/09/2013 | Dutch | |
| Abridged model | 31/12/2011 | 11/06/2012 | 28/09/2012 | Dutch | |
| Abridged model | 31/12/2010 | 10/06/2011 | 31/08/2011 | Dutch | |
| Abridged model | 31/12/2009 | 10/06/2010 | 30/07/2010 | Dutch | |
| Abridged model | 31/12/2008 | 10/06/2009 | 27/08/2009 | Dutch | |
| Abridged model | 31/12/2007 | 10/06/2008 | 26/08/2008 | Dutch | |
| Abridged model | 31/12/2006 | 11/06/2007 | 28/09/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
ROWAN CLAEYS | Directorsince 31/07/2006Managersince 31/07/2006ended |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
Rowan Gaston Pierre Claeys | Manager |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Prinsenbosstraat(KAG) 103, 3270 Scherpenheuvel-ZichemCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00235772 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Dokter R. CLAEYS, klinische biologieCurrent | accounts 2006 → 2025 | Accounts 2025 · 2026-00235772 |
Events
- 2025Annual accounts 202538,9 k €↑
- 2024Annual accounts 202419,7 k €↓
- 2023Annual accounts 202321,4 k €↓
- 2022Annual accounts 202257,6 k €↑
- 2021Annual accounts 202134,4 k €↑
- 2018Annual accounts 20183,7 k €↓
- 2017Annual accounts 20176,8 k €↓
- 2016Annual accounts 201616,2 k €↑
- 2015Annual accounts 20152,5 k €↓
- 2014Annual accounts 201410,1 k €↓
- 2013Annual accounts 201311,9 k €↓
- 2012Annual accounts 201213,3 k €↑
- 2011Annual accounts 201111,8 k €↑
- 2010Annual accounts 2010716,8 €↑
- 2009Annual accounts 2009-1,3 k €↓
- 2008Annual accounts 2008549,3 €↓
- 2007Annual accounts 20073,3 k €↓
- 2006Annual accounts 20067,8 k €
- 14/07/2006IncorporationPrivate limited company